These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33791035)

  • 1. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06544. PubMed ID: 33791036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06554. PubMed ID: 33791038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter J; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06557. PubMed ID: 33791041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General scientific guidance for stakeholders on health claim applications (Revision 1).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06553. PubMed ID: 33791037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 (Revision 1)
    ; Nutrition ; Nda A; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Salminen S; Schlatter J; Arcella D; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06555. PubMed ID: 33791039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific Opinion related to a notification from Lyckeby Starch AB on barley starch to be used in the manufacturing of several foods as ingredient, of the food additive modified starch and of glucose syrups pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling.
    ; Turck D; Castenmiller J; Hirsch Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Marchelli R; van Loveren H; Martínez SV; de Henauw S
    EFSA J; 2020 May; 18(5):e06118. PubMed ID: 37649494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Loveren HV; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Martínez SV
    EFSA J; 2021 Mar; 19(3):e06556. PubMed ID: 33791040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2017 Jan; 15(1):e04680. PubMed ID: 32625270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling.
    ; Turck D; Bohn T; Castenmiller J; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Marchelli R; Van Loveren H; Valtueña Martínez S; de Henauw S
    EFSA J; 2023 Sep; 21(9):e08240. PubMed ID: 37753350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
    EFSA J; 2017 May; 15(5):e04779. PubMed ID: 32625485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources (Revision 1).
    ; Younes M; Aggett P; Aguilar F; Crebelli R; Dusemund B; Filipič M; Frutos MJ; Galtier P; Gundert-Remy U; Kuhnle GG; Lambré C; Leblanc JC; Lillegaard IT; Moldeus P; Mortensen A; Oskarsson A; Stankovic I; Waalkens-Berendsen I; Woutersen RA; Wright M; Di Domenico A; Fairweather-Tait S; McArdle HJ; Smeraldi C; Gott D
    EFSA J; 2021 Mar; 19(3):e06552. PubMed ID: 33815621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific Guidance for the submission of dossiers on Food Enzymes.
    ; Lambré C; Barat Baviera JM; Bolognesi C; Cocconcelli PS; Crebelli R; Gott DM; Grob K; Lampi E; Mengelers M; Mortensen A; Rivière G; Steffensen IL; Tlustos C; Van Loveren H; Vernis L; Zorn H; Glandorf B; Herman L; Aguilera J; Andryszkiewicz M; Gomes A; Kovalkovicova N; Liu Y; Rainieri S; Chesson A
    EFSA J; 2021 Oct; 19(10):e06851. PubMed ID: 34721697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific substantiation of health claims in the EU.
    Flynn A
    Proc Nutr Soc; 2012 Feb; 71(1):120-6. PubMed ID: 21933455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of egg membrane hydrolysate as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Schlatter JR; Ackerl R; van Loveren H
    EFSA J; 2018 Jul; 16(7):e05363. PubMed ID: 32625994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of dried fruits of
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Maradona MP; Schlatter JR; van Loveren H; Matijević L; Knutsen HK
    EFSA J; 2021 Jun; 19(6):e06600. PubMed ID: 34135997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of an extension of use of
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; Siskos A; van Loveren H; Ackerl R; Knutsen HK
    EFSA J; 2023 Nov; 21(11):e8416. PubMed ID: 38035143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of UV-treated powder of whole yellow mealworm (
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Maradona MP; Siskos A; Schlatter JR; van Loveren H; Zakidou P; Ververis E; Knutsen HK
    EFSA J; 2023 Jun; 21(6):e08009. PubMed ID: 37274457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of β-hydroxybutyrate salts as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Albert O; Goumperis T; Knutsen HK
    EFSA J; 2022 Oct; 20(10):e07449. PubMed ID: 36254193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of xylo-oligosaccharides (XOS) as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter JR; Turla E; van Loveren H
    EFSA J; 2018 Jul; 16(7):e05361. PubMed ID: 32625993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.